Loading
Light therapy / Postpartum Depression (PPD) · Interventional Study
ClinicalTrials.gov · August 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned open-label feasibility study registered at ClinicalTrials.gov evaluating the acceptability and implementation of wearable morning bright light therapy for postpartum depression. No results have been posted in the registry record; the study is currently recruiting participants.
Interventional, Single Group, Open label, Other purpose. Postpartum Depression (PPD); Female; age from 18 Years. Intervention: Light therapy. n = 30. 1 site: United States.
This is a planned open-label feasibility study registered at ClinicalTrials.gov evaluating the acceptability and implementation of wearable morning bright light therapy for postpartum depression. No results have been posted in the registry record; the study is currently recruiting participants.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a registry record for a planned open-label feasibility study with no results posted; it describes an intervention study focused on implementation metrics rather than clinical efficacy.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07766161). This is a study registration, not published results. Lead sponsor: University of Michigan. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 30 participants (ESTIMATED). Conditions: Postpartum Depression (PPD). Interventions: DEVICE: Light therapy. Primary outcome measures: Retention rate , At approximately 5 weeks after treatment is started (post-treatment); Adherence rate (as assessed through self-report) , At approximately 5 weeks after treatment is started (post-treatment). Brief summary: The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.